These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 11422223)
1. The pathological consequences of anaemia. Silverberg DS; Iaina A; Wexler D; Blum M Clin Lab Haematol; 2001 Feb; 23(1):1-6. PubMed ID: 11422223 [TBL] [Abstract][Full Text] [Related]
2. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Silverberg DS; Wexler D; Blum M; Tchebiner JZ; Sheps D; Keren G; Schwartz D; Baruch R; Yachnin T; Shaked M; Schwartz I; Steinbruch S; Iaina A Nephrol Dial Transplant; 2003 Jan; 18(1):141-6. PubMed ID: 12480972 [TBL] [Abstract][Full Text] [Related]
3. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron? Silverberg DS; Wexler D; Iaina A J Nephrol; 2004; 17(6):749-61. PubMed ID: 15593047 [TBL] [Abstract][Full Text] [Related]
5. Anemia, chronic renal disease and congestive heart failure--the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Silverberg DS; Wexler D; Iaina A; Steinbruch S; Wollman Y; Schwartz D Int Urol Nephrol; 2006; 38(2):295-310. PubMed ID: 16868702 [TBL] [Abstract][Full Text] [Related]
6. Anaemia in heart failure: a common interaction with renal insufficiency called the cardio-renal anaemia syndrome. Palazzuoli A; Gallotta M; Iovine F; Nuti R; Silverberg DS Int J Clin Pract; 2008 Feb; 62(2):281-6. PubMed ID: 18081797 [TBL] [Abstract][Full Text] [Related]
7. The interaction between heart failure and other heart diseases, renal failure, and anemia. Silverberg DS; Wexler D; Iaina A; Schwartz D Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468 [TBL] [Abstract][Full Text] [Related]
8. The role of correction of anaemia in patients with congestive heart failure: a short review. Silverberg DS; Wexler D; Iaina A; Schwartz D Eur J Heart Fail; 2008 Sep; 10(9):819-23. PubMed ID: 18703380 [TBL] [Abstract][Full Text] [Related]
10. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia. Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060 [TBL] [Abstract][Full Text] [Related]
11. The anemia of heart failure. Silverberg DS; Wexler D; Palazzuoli A; Iaina A; Schwartz D Acta Haematol; 2009; 122(2-3):109-19. PubMed ID: 19907148 [TBL] [Abstract][Full Text] [Related]
12. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency]. Dimković N Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218 [TBL] [Abstract][Full Text] [Related]
13. Erythropoietin in cardiovascular diseases. van der Meer P; Voors AA; Lipsic E; van Gilst WH; van Veldhuisen DJ Eur Heart J; 2004 Feb; 25(4):285-91. PubMed ID: 14984916 [TBL] [Abstract][Full Text] [Related]
14. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. Silverberg DS; Wexler D; Sheps D; Blum M; Keren G; Baruch R; Schwartz D; Yachnin T; Steinbruch S; Shapira I; Laniado S; Iaina A J Am Coll Cardiol; 2001 Jun; 37(7):1775-80. PubMed ID: 11401110 [TBL] [Abstract][Full Text] [Related]
15. The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome. Silverberg DS Heart Fail Rev; 2011 Nov; 16(6):609-14. PubMed ID: 20865450 [TBL] [Abstract][Full Text] [Related]
16. Viewpoint: Heart failure and anaemia--a concept returns to the fore. Shaw R Circulation; 2006 Oct; 114(15):f157-8. PubMed ID: 17030699 [No Abstract] [Full Text] [Related]
17. Anaemia and heart failure: aetiology and treatment. Klutstein MW; Tzivoni D Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii7-10. PubMed ID: 16024833 [TBL] [Abstract][Full Text] [Related]
18. Epoetin alfa. A review of its clinical efficacy in the management of anaemia associated with renal failure and chronic disease and its use in surgical patients. Dunn CJ; Wagstaff AJ Drugs Aging; 1995 Aug; 7(2):131-56. PubMed ID: 7579784 [TBL] [Abstract][Full Text] [Related]
19. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. Silverberg DS; Wexler D; Blum M; Keren G; Sheps D; Leibovitch E; Brosh D; Laniado S; Schwartz D; Yachnin T; Shapira I; Gavish D; Baruch R; Koifman B; Kaplan C; Steinbruch S; Iaina A J Am Coll Cardiol; 2000 Jun; 35(7):1737-44. PubMed ID: 10841219 [TBL] [Abstract][Full Text] [Related]
20. Effects of treatment with epoetin beta on outcomes in patients with anaemia and chronic heart failure. Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Scherhag A; Schwartz D Kidney Blood Press Res; 2005; 28(1):41-7. PubMed ID: 15489560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]